References
- Shlobin NA, Dahdaleh NS. Cervical spine manifestations of rheumatoid arthritis: a review. Neurosurg Rev. 2021;44:1957–65.
- Joaquim AF, Appenzeller S. Cervical spine involvement in rheumatoid arthritis - A systematic review. Autoimmun Rev. 2014;13:1195–202.
- O'Horo JC, Sampathkumar P. Infections in Neurocritical Care. Neurocrit Care. 2017;27:458–67.
- Seidelman J, Lewis SS. Neurosurgical Device-Related Infections. Infect Dis Clin North Am. 2018;32:861–76.
- Karvouniaris M, Brotis A, Tsiakos K, Palli E, Koulenti D. Current Perspectives on the Diagnosis and Management of Healthcare-Associated Ventriculitis and Meningitis. Infect Drug Resist. 2022;15:697–721.
- Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clinical Infectious Diseases. 2017, 64:E34–65.
- Lewin JJ, Cook AM, Gonzales C, et al. Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study. Neurocrit Care. 2019;30:609–16.
- World Health Organization. Global priority list of antibiotic resistant bacteria to guide research, discovery, and development of new antibiotics. 2017.
- O'Neill J: Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. London. 2014.
- Bavaro DF, Romanelli F, Stolfa S, et al. Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review. Infect Dis. 2021;53:206–11.
- Marcelo C, De Gea Grela A, Palazuelos MM, et al. Clinical Cure of a Difficult-to-Treat Resistant Pseudomonas aeruginosa Ventriculitis Using Cefiderocol: A Case Report and Literature Review. Open Forum Infect Dis. 2022;9(8):ofac391.
- Syed YY. Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections. Drugs. 2021;81:1559–71.
- Luque-Paz D, Bennis Y, Jaubert P et al: Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis. Journal of Antimicrobial Chemotherapy. 2022;77:1787–9.